Skip Nav Destination
Issues
1 December 2002
ISSN 1055-9965
EISSN 1538-7755
Review
Commentary
Point/Counterpoint
Research Articles
Do Thyroid Disorders Increase the Risk of Breast Cancer?1
Michael S. Simon; Mei-Tzu C. Tang; Leslie Bernstein; Sandra A. Norman; Linda Weiss; Ronald T. Burkman; Janet R. Daling; Dennis Deapen; Suzanne G. Folger; Kathi Malone; Polly A. Marchbanks; Jill A. McDonald; Brian L. Strom; Hoyt G. Wilson; Robert Spirtas
Semiquantitation of Polycyclic Aromatic Hydrocarbon-DNA Adducts in Human Esophagus by Immunohistochemistry and the Automated Cellular Imaging System
Hilde E. van Gijssel; Rao L. Divi; Ofelia A. Olivero; Mark J. Roth; Guo-Qing Wang; Sanford M. Dawsey; Paul S. Albert; You-Lin Qiao; Philip R. Taylor; Zhi-Wei Dong; Jeffrey A. Schrager; David E. Kleiner; Miriam C. Poirier
Ursodeoxycholic Acid and F6-D3 Inhibit Aberrant Crypt Proliferation in the Rat Azoxymethane Model of Colon Cancer: Roles of Cyclin D1 and E-Cadherin1
Ramesh K. Wali; Sharad Khare; Maria Tretiakova; Greg Cohen; Lan Nguyen; John Hart; Julia Wang; Ming Wen; Akila Ramaswamy; Loren Joseph; Michael Sitrin; Thomas Brasitus; Marc Bissonnette
Short Communications
The TP53 Codon 72 Polymorphism May Affect the Function of TP53 Mutations in Breast Carcinomas but not in Colorectal Carcinomas1
Anita Langerød; Ida R. K. Bukholm; André Bregård; Per Eystein Lønning; Tone Ikdal Andersen; Torleiv O. Rognum; Gunn Iren Meling; Ragnhild A. Lothe; Anne-Lise Børresen-Dale
Null Results in Brief
Correction
Advertisement
Email alerts
NOTICE: This notice serves to inform the reader that, in 2023, AACR received a donation by Pfizer of the rights to royalties from the sale—within the United States—of Bavencio® (avelumab), a pharmaceutical owned by Merck. None of these funds are being, or will be, used to directly support any specific publication or author. If an individual article is published that deals with this particular drug, such article will include standard financial disclosures per AACR journal policy. For more detail regarding AACR’s established policies for authors, please go to https://aacrjournals.org/pages/editorial-policies#coi.